Selected Variants of the Steroid-5-Alpha-Reductase Isoforms SRD5A1 and SRD5A2 and the Sex Steroid Hormone Receptors ESR1, ESR2, and PGR: No Association with Female Pattern Hair Loss Identified

    February 2012 in “ Experimental Dermatology
    Silke Redler, Rachid Tazi-Ahnini, Dmitriy Drichel, Mary P. Birch, Felix F. Brockschmidt, K. Dobson, Kathrin A. Giehl, Melanie Refke, Nadine Kluck, Roland Kruse, Gerhard Lutz, Hans Wolff, Markus Böhm, Tim Becker, Markus M. Nöthen, Regina C. Betz, Andrew G. Messenger
    Image of study
    TLDR No link found between specific genes and female pattern hair loss.
    This study investigated the association between certain genetic variants related to sex hormones and steroid-5-alpha-reductase genes and female pattern hair loss (FPHL). The study found no significant association between these genetic variants and FPHL, suggesting that these genes may not be involved in the development of FPHL. The study recommends future genetic studies of FPHL to include systematic genome-wide approaches.
    Discuss this study in the Community →

    Research cited in this study

    20 / 20 results

    Related Community Posts Join

    6 / 661 results

      community DHT and 5AR respect post, it's importance within the brain

      in Research/Science  111 upvotes 1 year ago
      The conversation discusses whether to use finasteride for hair loss, considering its role in inhibiting DHT and 5AR, which can affect brain function and mood. Some users report anxiety and depression from finasteride, while others do not experience these side effects and emphasize the importance of DHT for brain and prostate health.

      community Why does it seem everyone favors finasteride over dutasteride?

      in Female  62 upvotes 1 year ago
      The conversation discusses preferences for hair loss treatments, specifically finasteride over dutasteride. Users share personal experiences, cost considerations, FDA approval status, and potential side effects, with some switching between treatments to find what works best for them.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Similar Research

    5 / 1000+ results